Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder

Fig. 4

Enrichment plots from gene set enrichment analysis. Gene sets enriched in MTHFD2 high expression phenotype were analyzed: A NF-κB activation. B Mitotic metaphases and anaphase. C Mitotic prometaphases. D JAK/STAT. E Cancer immunotherapy by PD1 blockade. F Signaling by EGFR in cancer. G MAPK family signaling cascades. H PI3K/AKT/mTOR. I Senescence and autophagy in cancer pathways

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us